跳至主要内容
临床试验/CTRI/2024/07/070917
CTRI/2024/07/070917尚未招募不适用

Expression of Programmed Death -Ligand 1 (PD-L1) and CD8 in oral squamous cell carcinoma and its association with clinicopathological parameters

Maulana Azad Medical College1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年8月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
试验地点
1
主要终点
Proportion of cases of oral squamous cell carcinoma showing PD-L1 and CD8 expression

研究概览

简要总结

Oral  cancers  constitute roughly one-fourth of global occurrences. Most common histological subtype is oral squamous cell carcinoma. PD-L1  is expressed on antigen presenting cells , it causes T cell to undergo apoptosis, so PD-L1 binding to PD-L1 receptors on T cells can suppress antitumor immune responses. Tumor grade and prognosis are associated  with PD-L1 expression. Tumor infiltrating CD8+lymphocytes (TILs), play a role in the host’s  immunological response to Tumor cells.

There is paucity of studies in Indian literature on the expression of Programmed Death Ligand (PD-L1) and CD8 in oral squamous cell carcinoma and its association with clinicopathological parameters.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • All the newly diagnosed cases of primary oral squamous cell carcinoma whose samples are received in the Department of Pathology,MAMC 2) Age more than 18 years.

排除标准

  • Patients who have received radiotherapy and/or chemotherapy.
  • Patients having previous history of any other malignancy.

结局指标

主要结局

Proportion of cases of oral squamous cell carcinoma showing PD-L1 and CD8 expression

时间窗: Baseline

次要结局

  • Association between expression of PD-L1 and CD8 with clinicopathological parameters like age, Sex, duration of symptoms, tumor size, location, grade, stage, metastasis, lympho-vascular invasion, perineural invasion.(Baseline)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Pragya Nandini

Maulana Azad Medical college

研究点 (1)

Loading locations...

相似试验